Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Ensho Joins Race To Develop An Oral Integrin Inhibitor For IBD
Start-Up Licensed Lead Drug From Eisai Subsidiary
Jun 27 2024
•
By
Mandy Jackson
Ensho is launching with a new CEO coming from Telavant • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business